Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Rang in Aktien #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Aktienkurs
$12.65
Marktkapitalisierung
$114.00B
Veränderung (1 Tag)
1.36%
Veränderung (1 Jahr)
3.52%
Land
DE
Handel Fresenius SE & Co. KGaA (FSNUY)

Kategorie

Operative Marge für Fresenius SE & Co. KGaA (FSNUY)
Operative Marge zum July 2026 TTM: 9.45%
Laut den neuesten Finanzberichten und dem Aktienkurs von Fresenius SE & Co. KGaA beträgt die aktuelle operative Marge (TTM) 9.45%. Am Ende des Jahres 2023 lag die operative Marge bei 5.13%.
Historie der operativen Marge von Fresenius SE & Co. KGaA von 2002 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 9.45% 15.81%
2024 8.16% 59.06%
2023 5.13% -40.28%
2022 8.59% -22.47%
2021 11.08% -8.35%
2020 12.09% -7.57%
2019 13.08% -1.28%
2018 13.25% -2.14%
2017 13.54% -9.01%
2016 14.88% 6.06%
2015 14.03% 4.70%
2014 13.40% -8.91%
2013 14.71% -4.85%
2012 15.46% -0.32%
2011 15.51% 2.44%
2010 15.14% 4.27%
2009 14.52% 21.30%
2008 11.97% -68.59%
2007 38.11% 2.01%
2006 37.36% -6.13%
2005 39.80% 6.05%
2004 37.53% 250.09%
2003 10.72% -0.65%
2002 10.79% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
15.67% -98.34%
US
18.60% -98.03%
SA
16.14% -98.29%
US
5.17% -99.45%
CN
15.01% -98.41%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.